Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Hematology

Building Your Care Team and Preparing for Your First Visit

At a Glance

A multidisciplinary care team led by a hematologist is essential for managing Immune Thrombocytopenia (ITP). For your first visit, bring a complete list of medications, a symptom timeline, family history, and past lab results to help your doctor tailor a treatment plan to your specific needs.

A new ITP diagnosis is the beginning of a long-term relationship with a specialized medical team. Because ITP is a rare and nuanced condition, the “right” team is one that combines deep medical expertise with a willingness to listen to your priorities and quality-of-life concerns [1][2].

Your Core Care Team

While a hematologist is the lead, ITP often touches many parts of your health, requiring a multidisciplinary approach—meaning several types of experts working together [3][4].

  • Hematologist: The specialist in blood disorders who will lead your diagnosis, monitoring, and treatment [5].
  • Specialized Nurses and Pharmacists: These team members are often your best resource for education, managing medication side effects, and helping with insurance for expensive specialty drugs like TPO-RAs [1][4].
  • Primary Care Physician (PCP) or Pediatrician: They coordinate your overall health and can often handle routine blood draws once a stable plan is in place [6].
  • Secondary Specialists: Depending on your specific case, you may need to see an immunologist (for immune system issues), a gastroenterologist (to check for H. pylori bacteria), or a gynecologist (to manage heavy menstrual bleeding) [3][7][8].

Preparing for Your First Visit

The first consultation is your opportunity to provide the “detective clues” the hematologist needs to rule out other conditions. You should bring:

  1. A Complete Medication & Supplement List: Include everything—prescriptions, herbal supplements, and especially over-the-counter pain relievers like aspirin, ibuprofen, or naproxen, which are critical to identify because they inhibit platelet function and increase bleeding risks [9][10].
  2. Symptom Timeline: When did the first bruise or red dots (petechiae) appear? Did this happen after a viral illness, a new medication, or a vaccination? [11][12].
  3. Family History: Note any relatives with low platelets, “easy bleeding,” or autoimmune diseases like Lupus. For certain “look-alike” conditions, history of hearing loss or kidney issues in the family is also important.
  4. Past Labs: If you have copies of previous blood tests from years ago, bring them. Showing a historically “normal” platelet count helps prove the current drop is a new event [5].

Evaluating Your Doctor

Not all hematologists see ITP regularly. An expert in ITP should be familiar with the latest ASH (American Society of Hematology) or International Consensus guidelines [13][14]. They should be able to explain not just how to raise your count, but why they are choosing a specific path—whether that is a “watch and wait” approach for a child or a specific second-line drug for an adult [15][16][17].

A good care team doesn’t just treat your platelet number; they treat you as a whole person, accounting for your anxiety, your fatigue, and your lifestyle goals [4][2].

Return to the Home Page.

Common questions in this guide

What kind of doctor treats Immune Thrombocytopenia (ITP)?
While a hematologist is the lead specialist who will manage your diagnosis and treatment, you will likely need a multidisciplinary team. This can include specialized nurses, pharmacists, your primary care doctor or pediatrician, and sometimes other specialists like immunologists or gynecologists.
What should I bring to my first ITP hematology appointment?
You should bring a complete list of all medications and supplements, a timeline of when your symptoms started, your family medical history, and copies of any past blood test results. This helps your hematologist rule out other conditions and establish a baseline.
Why is it important to tell my doctor about over-the-counter pain medicines?
It is critical to mention over-the-counter pain relievers like aspirin, ibuprofen, or naproxen because they inhibit platelet function. For someone with ITP, taking these medications can significantly increase your risk of bleeding.
How do I know if my doctor is an expert in treating ITP?
Look for a hematologist who regularly treats ITP patients and follows the latest guidelines from the American Society of Hematology (ASH) or the International Consensus. They should also be willing to discuss how treatments will impact your overall quality of life and fatigue levels.
Will I automatically be put on medication for my ITP?
Not everyone with ITP requires immediate medication. Depending on your symptoms and platelet counts, your doctor might recommend a 'watch and wait' approach to monitor your condition, which is a recognized and common strategy, especially in children.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with ITP do you currently manage, and what is your approach to following the latest international consensus guidelines?
  2. 2.How do you decide when a patient has transitioned from 'newly diagnosed' to 'chronic' and needs a change in strategy?
  3. 3.What is your philosophy on 'watching and waiting' versus active treatment for a patient with my (or my child's) specific symptoms?
  4. 4.What is your protocol for weaning off steroids, and when do we consider steroid-sparing medications?
  5. 5.How do you incorporate my quality of life and fatigue levels into your treatment decisions?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Second-line therapies in immune thrombocytopenia.

    Grace RF, Neunert C

    Hematology. American Society of Hematology. Education Program 2016; (2016(1)):698-706 doi:10.1182/asheducation-2016.1.698.

    PMID: 27913549
  2. 2

    Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use.

    Gilbert MM, Grimes AB, Kim TO, Despotovic JM

    Patient preference and adherence 2020; (14()):1237-1250 doi:10.2147/PPA.S192481.

    PMID: 32801654
  3. 3

    Immune Thrombocytopenic Purpura (ITP) With Ulcerative Colitis (UC).

    Mohammed SK, Budamagunta S, Khan WA, et al.

    Cureus 2024; (16(10)):e72778 doi:10.7759/cureus.72778.

    PMID: 39618596
  4. 4

    Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial.

    Arnold DM, Heddle NM, Cook RJ, et al.

    The Lancet. Haematology 2020; (7(9)):e640-e648 doi:10.1016/S2352-3026(20)30227-1.

    PMID: 32853584
  5. 5

    Lifting the fog over ITP.

    Choi PY

    Platelets 2020; (31(3)):283-284 doi:10.1080/09537104.2020.1732747.

    PMID: 32124683
  6. 6

    [Protocol for the study and treatment of primary immune thrombocytopenia: PTI-2018].

    Monteagudo E, Astigarraga I, Cervera Á, et al.

    Anales de pediatria 2019; (91(2)):127.e1-127.e10 doi:10.1016/j.anpedi.2019.04.014.

    PMID: 31178291
  7. 7

    Disseminated tuberculosis with severe immune thrombocytopenia.

    Rama Krishna M, Gottam US, Mahendra N

    Respiratory medicine case reports 2019; (27()):100812 doi:10.1016/j.rmcr.2019.02.013.

    PMID: 30949428
  8. 8

    Inflammatory Bowel Disease and Immune Thrombocytopenic Purpura: Combined Immune Dysregulation in an Adolescent.

    Queliza K, Ihekweazu FD, Ali A, Kellermayer R

    Annals of clinical and laboratory science 2017; (47(2)):226-228.

    PMID: 28442528
  9. 9

    Quick drop of platelet counts in children with chronic immune thrombocytopenia after COVID-19 mRNA vaccination: case reports.

    Lassandro G, Carriero F, Palladino V, et al.

    Clinical and experimental vaccine research 2022; (11(3)):290-293 doi:10.7774/cevr.2022.11.3.290.

    PMID: 36451665
  10. 10

    Immune thrombocytopenia in a 68-year-old woman after COVID-19 vaccination.

    Kenney A, Adhikari A

    Clinical case reports 2021; (9(8)):e04689 doi:10.1002/ccr3.4689.

    PMID: 34466248
  11. 11

    A Case of Immune Thrombocytopenic Purpura Secondary to Pulmonary Tuberculosis.

    Panda S, Meher LK, Dalai SP, et al.

    Journal of clinical and diagnostic research : JCDR 2016; (10(10)):OD12-OD13 doi:10.7860/JCDR/2016/21365.8726.

    PMID: 27891382
  12. 12

    Immune thrombocytopenic purpura associated with coronavirus disease 2019 infection in an asymptomatic young healthy patient.

    Lobos P, Lobos C, Aravena P

    JAAD case reports 2020; (6(11)):1129-1131 doi:10.1016/j.jdcr.2020.08.037.

    PMID: 32923567
  13. 13

    Evidence-based management of immune thrombocytopenia: ASH guideline update.

    Neunert CE, Cooper N

    Hematology. American Society of Hematology. Education Program 2018; (2018(1)):568-575 doi:10.1182/asheducation-2018.1.568.

    PMID: 30504359
  14. 14

    The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia.

    Neunert CE, Arnold DM, Grace RF, et al.

    Blood advances 2024; (8(13)):3578-3582 doi:10.1182/bloodadvances.2023012541.

    PMID: 38608258
  15. 15

    Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial.

    Heitink-Pollé KMJ, Uiterwaal CSPM, Porcelijn L, et al.

    Blood 2018; (132(9)):883-891 doi:10.1182/blood-2018-02-830844.

    PMID: 29945954
  16. 16

    The child with immune thrombocytopenia: to treat or not to treat, is that still the question?

    Cooper N, Cines DB

    Haematologica 2019; (104(11)):2132-2134 doi:10.3324/haematol.2019.229179.

    PMID: 31666343
  17. 17

    Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

    Provan D, Arnold DM, Bussel JB, et al.

    Blood advances 2019; (3(22)):3780-3817 doi:10.1182/bloodadvances.2019000812.

    PMID: 31770441

This guide is intended for educational purposes to help you prepare for your ITP doctor's visits. It does not replace professional medical advice, diagnosis, or treatment from your hematologist or healthcare provider.

Get notified when new evidence is published on Immune thrombocytopenia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.